5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.
By J. Vincent, G. Mignot, Fanny Chalmin, S. Ladoire, M. Bruchard, Angélique Chevriaux, F. Martin, L. Apetoh, C. Rébé, François Ghiringhelli. Cancer Research, 2010
1,247 citations recorded by the source corpus.
Myeloid-derived suppressor cells (MDSC) accumulate in the spleen and tumor bed during tumor growth. They contribute to the immune tolerance of cancer notably by inhibiting the function of CD8(+) T cells. Thus, their elimination may hamper tumor growth by enhancing antitumor T-cell functions. We have previously reported that some anticancer agents relied on T cell-dependent anticancer responses to achieve maximal efficacy. However, the effect of anticancer agents on MDSC has remained largely unexplored. In this study, we observed that gemcitabine and 5-fluorouracil (5FU) were selectively cytotoxic on MDSC. In vivo, the treatment of tumor-bearing mice with 5FU led to a major decrease in the number of MDSC in the spleens and tumor beds of animals whereas no significant effect on T cells, natural killer cells, dendritic cells, or B cells was noted. Interestingly, 5FU showed a stronger efficacy over gemcitabine to deplete MDSC and selectively induced MDSC apoptotic cell death in vitro and in vivo. The elimination of MDSC by 5FU increased IFN-gamma production by tumor-specific CD8(+) T cells infiltrating the tumor and promoted T cell-dependent antitumor responses in vivo. Altogether, these findings suggest that the antitumor effect of 5FU is mediated, at least in part, by its selective cytotoxic action on MDSC.
Subfields: Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/4f73fefa5876570fc29299589e4b609c083d240d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Oncology
Citations in the corpus
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. (2015, background): “Immunological Effects of Targeted Anticancer Agents Agent Setting Effect Notes Reference Bevacizumab transplantable murine CRC depletes TREG cells mechanism involving KDR Terme et al., 2013 Dasatinib CML favors the expansion of circulating CTLs and NK cells correlates with molecular response to chem”
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. (2016, background): “In addition to antiangiogenic effects, blockade of VEGF has been reported to possess immunomodulatory effects such as promoting increased effector T-cell trafficking [95, 96], and reducing MDSCs, T-regulatory cells, and suppressive cytokines at the tumor microenvironment [97].”
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. (2015, background): “In addition to antiangiogenic effects, blockade of VEGF has been reported to possess immunomodulatory effects such as promoting increased effector T-cell trafficking [95, 96], and reducing MDSCs, T-regulatory cells, and suppressive cytokines at the tumor microenvironment [97].”